Litcius/Paper detail

Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer

Ian F. Tannock, Madeline Pe, Christopher M. Booth, Michael Brundage, Nathan I. Cherny, Corneel Coens, Elizabeth A. Eisenhauer, Jan Geißler, Johannes M. Giesinger, Bishal Gyawali, Sjoukje F. Oosting, Gregory R. Pond, Jaap C. Reijneveld, Enrique Soto-Perez-de-Celis, Michelle Tregear, Winette T.A. van der Graaf

2025The Lancet Oncology8 citationsDOIOpen Access PDF

Topics & Concepts

MedicineClinical trialQuality of life (healthcare)CancerOncologyClinical OncologyCancer treatmentInternal medicineMedical physicsNursingCancer survivorship and careMultiple and Secondary Primary CancersCancer Treatment and Pharmacology
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer | Litcius